Regulators in the UK and US are the first to approve GSK's Exdensur, a long-acting, twice-yearly IL-5 inhibitor for severe ...

By Zachary T. Sampson, Shreya Vuttaluru and Bethany Barnes Times Staff Writers Dec. 17, 2025 When they arrived in Longboat ...

Months after public health officials say they caused the nation’s largest measles surge in 30 years, some West Texas Mennonites have grown more skeptical of the mainstream medical system.